-+ 0.00%
-+ 0.00%
-+ 0.00%

Evercore ISI Group Maintains Outperform on TG Therapeutics, Lowers Price Target to $71

Benzinga·11/10/2026 14:12:47
Listen to the news
Evercore ISI Group analyst Michael DiFiore maintains TG Therapeutics (NASDAQ:TGTX) with a Outperform and lowers the price target from $73 to $71.